Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
org/Langmuir
2011 American Chemical Society
Introduction
Since the recent discovery of RNA interference as a powerful
mechanism for regulating gene expression,1,2 the potential to use
siRNA (small interfering RNA) as a novel therapeutic modality
has attracted significant attention and has been heavily exploited
in academia and the biotech and pharmaceutical industries.3,4
Although the use of naked siRNA for localized treatment in lung
and eye has progressed rapidly through preclinical and clinical
stages,4-6 significant challenges still remain for the systemic administration of siRNA for broader therapeutic indications. Among
them, one of the biggest hurdles is the lack of highly efficient
delivery vehicles to enable safe and efficacious delivery of siRNA
for systemic administration.7
Lipid-based delivery systems such as liposomes, lipoplexes, and
lipid nanoparticles have been broadly utilized to deliver plasmid
*Corresponding author. E-mail: jingtao_zhang@merck.com.
(1) Fire, A.; Xu, S.; Montgomery, M. K.; Kostas, S. A.; Driver, S. E.; Mello,
C. C. Nature 1998, 391, 80611.
(2) Elbashir, S. M.; Harborth, J.; Lendeckel, W.; Yalcin, A.; Weber, K.; Tuschl,
T. Nature 2001, 411, 494498.
(3) Bumcrot, D.; Manoharan, M.; Koteliansky, V.; Sah, D. W. Y. Nat. Chem.
Biol. 2006, 2, 711719.
(4) Castanotto, D.; Rossi, J. J. Nature 2009, 457, 426433.
(5) de Fougerolles, A.; Vornlocher, H. P.; Maraganore, J.; Lieberman, J. Nat.
Rev. Drug Discovery 2007, 6, 443453.
(6) Sepp-Lorenzino, L.; Ruddy, M. K. Clin. Pharmacol. Ther. 2008, 84, 628632.
(7) Whitehead, K. A.; Langer, R.; Anderson, D. G. Nat. Rev. Drug Discovery
2009, 8, 129138.
(8) Heyes, J.; Palmer, L.; Bremner, K.; MacLachlan, I. J. Controlled Release
2005, 107, 276287.
(9) Santel, A.; Aleku, M.; Keil, O.; Endruschat, J.; Esche, V.; Fisch, G.; Dames,
S.; Loffler, K.; Fechtner, M.; Arnold, W.; Giese, K.; Klippel, A.; Kaufmann, J.
Gene Ther. 2006, 13, 12221234.
(10) Akinc, A.; Zumbuehl, A.; Goldberg, M.; Leshchiner, E. S.; Busini, V.;
Hossain, N.; et al. Nat. Biotechnol. 2008, 26, 561569.
DOI: 10.1021/la104590k
1907
Article
depend not only on the ratio of the amino lipids to neutral lipids,
but also on the ionization state of the amine headgroup. It is
widely known that physicochemical properties of lipid nanoparticles, such as particle size, morphology, and especially surface
charge, have a dramatic impact on the performance of delivery
vehicles.13,16-20 For example, it was demonstrated in DNA
delivery that surface charges of lipid-DNA nanoparticles under
physiological conditions played a critical role in determining the
interaction of lipid nanoparticles with cell membranes and ultimately determined the internalization of the nanoparticles by cells
and the toxicity induced during delivery.19-23 Later, it was also
suggested that the surface charge densities of lipid-DNA nanoparticles in acidic environments such as those found in cellular
endosomes determined the rate of membrane fusion between
lamellar lipid vehicles and endosomes, which was one of the ratelimiting steps for transfection processes.17,24,25 Therefore, understanding the charge state of ionizable amino lipids by measuring
pKa could prove to be crucial to the understanding of the charge
behavior of lipids and lipid nanoparticles during assembly, systemic circulation, internalization, and intracellular trafficking,
and could contribute significantly to the design and development
of lipid nanoparticles for siRNA delivery.
Most conventional approaches to determining the pKa of
pharmaceutical compounds,26-28 such as potentiometric titration, spectrophotometric titration, capillary electrophoresis, or
chromatographic measurements, cannot be directly applied to
determine the relevant pKa value of ionizable amino lipids used
for siRNA delivery. For example, potentiometric titration, the
best option in determining ionization constants, requires the
titrated compounds to have sufficient aqueous solubility and be
fully dissolved in solution; unprotonated amino lipids generally
possess extremely low aqueous solubility, and they form colloidal
aggregates after protonation due to their amphiphilic nature. In
addition, it is widely known that the value of pKa is strongly affected by environmental conditions such as dielectric constant, ionic
strength, and the presence of neighboring charges.29,30 For instance, the pKa of undecyl-hydroxycoumarin shifted significantly
higher in a hydrophobic environment compared with the value
when it was in aqueous solution; the measured pKa values also
changed dramatically depending on whether it was incorporated
in a cationic or anionic surfactant micelle.29 Consequently, in
order to gain a relevant understanding of the ionization status of
amino lipids, the determination of pKa should be conducted in an
(16) Barteau, B.; Chevre, R.; Letrou-Bonneval, E.; Labas, R.; Lambert, O.;
Pitard, B. Curr. Gene Ther. 2008, 8, 313323.
(17) Ewert, K. K.; Ahmad, A.; Evans, H. M.; Safinya, C. R. Expert Opin. Biol.
Ther. 2005, 5, 3353.
(18) Resina, S.; Prevot, P.; Thierry, A. R. PLoS One 2009, 4, 11.
(19) Ahmad, A.; Evans, H. M.; Ewert, K.; George, C. X.; Samuel, C. E.; Safinya,
C. R. J. Gene Med. 2005, 7, 739748.
(20) Caracciolo, G.; Pozzi, D.; Caminiti, R.; Marchini, C.; Montani, M.; Amici,
A.; Amenitsch, H. J. Phys. Chem. B 2008, 112, 1129811304.
(21) Lv, H. T.; Zhang, S. B.; Wang, B.; Cui, S. H.; Yan, J. J. Controlled Release
2006, 114, 100109.
(22) Mislick, K. A.; Baldeschwieler, J. D. Proc. Natl. Acad. Sci. U.S.A. 1996, 93,
1234912354.
(23) Mounkes, L. C.; Zhong, W.; Cipres-Palacin, G.; Heath, T. D.; Debs, R. J. J.
Biol. Chem. 1998, 273, 2616426170.
(24) Budker, V.; Gurevich, V.; Hagstrom, J. E.; Bortzov, F.; Wolff, J. A. Nat.
Biotechnol. 1996, 14, 760764.
(25) Lin, A. J.; Slack, N. L.; Ahmad, A.; George, C. X.; Samuel, C. E.; Safinya,
C. R. Biophys. J. 2003, 84, 33073316.
(26) Albert, A.; Serjeant, E. P. Ionization Constants of Acids and Bases: A
Laboratory Manual; Methuen: London, 1962.
(27) Allen, R. I.; Box, K. J.; Comer, J. E. A.; Peake, C.; Tam, K. Y. J. Pharm.
Biomed. Anal. 1998, 17, 699712.
(28) Poole, S. K.; Patel, S.; Dehring, K.; Workman, H.; Poole, C. F. J.
Chromatogr., A 2004, 1037, 445454.
(29) Fernandez, M. S.; Fromherz, P. J. Phys. Chem. 1977, 81, 17551761.
(30) Fromherz, P. Biochim. Biophys. Acta 1973, 323, 326334.
Zhang et al.
Zhang et al.
Article
a
!
pH - pKa
1 exp
b
1909
Article
Zhang et al.
Figure 1. (a) Potentiometric titration of lipid 1 (1.2 mM) prepared in neutral surfactant micelles (120 mM); surfactant micelles and titration
media were in 0.15 M ionic strength adjusted water. (b) Buffer capacity analysis (d(OH-)/d pH) of the potentiometric titration in part (a); the
squares (0) correspond to experimental data and the line came from the fitting of the data. The peak in maximum buffer capacity
corresponded to the pKa of the titrated lipid.
Table 1. Measured (Micelle Method and TNS Fluorescence Method) and Calculated pKa Values of Amino Lipids and Model Compounds at 25 Ca
Downloaded by HARVARD UNIV on September 1, 2015 | http://pubs.acs.org
Publication Date (Web): January 20, 2011 | doi: 10.1021/la104590k
ID
lipid headgroup
lipid tail L1
lipid tail L2
calculated pKab
1
dimethyl amine
linoleyl
octyl cholesteryl ether
7.9
7.7
8.6
2
dimethyl amine
linoleyl
butyl cholesteryl ether
8.2
8.1
8.6
3
morpholine
linoleyl
butyl cholesteryl ether
5.7
6.1
6.8
4
pyrrolidine
linoleyl
butyl cholesteryl ether
8.4
8.0
9.6
5
dimethyl amine
oleyl
hexyl cholesteryl ether
8.1
8.2
8.6
6
diethyl amine
oleyl
hexyl cholesteryl ether
7.9
7.3
9.6
7
1-methyl pyrrolidine
oleyl
hexyl cholesteryl ether
7.6
7.3
9.7
8
3-fluoropiperidine
oleyl
hexyl cholesteryl ether
6.6
6.1
6.6
9
pyrrolidine
oleyl
hexyl cholesteryl ether
8.1
7.8
9.6
10
piperidine
oleyl
hexyl cholesteryl ether
7.4
7.1
8.5
11
morpholine
oleyl
hexyl cholesteryl ether
5.3
4.8
6.8
12
imidazole
oleyl
hexyl cholesteryl ether
5.6
5.6
6.9
13
benzyl amine
oleyl
hexyl cholesteryl ether
5.2
4.1
7.7
14
methyl piperazine
oleyl
hexyl cholesteryl ether
2.8/7.9
7.9
3.3/7.6
9.1
8.8
3-(dimethylamino)-1,2-propanediolc
c
9.7
8.8
3-piperidino-1,2-propanediol
a
Measured pKa values for amino lipids are determined either by potentiometric titration in the presence of neutral surfactants (micelle method) or by a
TNS fluorescence approach. b Calculated pKa values are obtained from ACD Laboratories v 11.0 software. c pKa values of model compound are
determined directly in the absence of micelles.
desired pharmacokinetic properties. Recently, strategies to incorporate sterols as part of lipid structures were shown to further
improve biomembrane properties, and formulations based on
these sterol-modified lipids were successfully applied in drug
delivery and siRNA delivery.11,31,33 For instance, a new class of
asymmetric cationic lipids consisting of a cholesteryl ether tail and
an aliphatic tail (see the above generic lipid structure) was found
effective in mediating the delivery of siRNA in vitro and in
vivo.11,31 To understand the relevant ionization behavior of these
lipids, we decided to develop appropriate methods to evaluate the
pKa of a series of these ionizable amino lipids. Headgroups of
these ionizable amino lipids (Table 1) were selected to span across
a broad range of calculated pKa values to evaluate the SAR of
lipids. A subset of the lipids was chosen to have identical tails to
allow for a simple assessment of the impact of headgroup structures on pKa.
From Figure 1a, it is clear that potentiometric titration of lipids
dissolved in micelles resembled those expected from the titration
of fully soluble molecules. This shows that the micelle titration
method can be used to understand the ionization behavior of
cationic lipids. Buffer capacity analysis in Figure 1b demonstrates
that the pKa of cationic lipid can be easily obtained from the
potentiometric titration data. Comparison between the pKa values of amino lipids prepared in micelles and the pKa values of
(33) Huang, Z.; Szoka, F. C., Jr. J. Am. Chem. Soc. 2008, 130, 1570212.
Zhang et al.
Article
0.5
0.4
8.2
1
0.8
8.2
1.25
1
8.2
1.5
1.2
8.1
2
1.6
8.0
2.5
2
7.9
5
4
7.7
10
8
7.4
a
pKa values for amino lipids are determined by potentiometric
titration in the presence of neutral surfactants (micelle method).
b
Micelle aggregate number of 80 is used in the calculation.34
DOI: 10.1021/la104590k
1911
Article
This suggests that TNS can be used as a reporter molecule for the
charge state of amino lipids.
To further determine the usefulness of TNS to measure pKa of
amino lipids, TNS fluorescence was evaluated at a broader pH
range for multiple lipids. Figure 3 shows the representative plot of
TNS fluorescence as a function of pH in the presence of lipid 2 and
five other cationic lipids. It is clear that TNS fluorescence is
significantly affected by the charge states of the lipids, and the pHdependent fluorescence data follow a simple sigmoid function.
The profiles shown here are consistent with the TNS binding
data on other lipids previously reported in the literature.8,14 The
resemblance of these curves to the sigmoid function of an ionization event suggests that TNS can be used to measure the pKa of
amino lipids. A fit of the data using a sigmoid function reveals the
pH at which fluorescence values are half of the maximum fluorescence values. These pH values correspond to apparent pKa
values of the amino lipids. Apparent pKa values of amino lipids
from TNS fluorescence assays are reported in Table 1 and compared with the pKa values measured from micelle titration method
and calculation. It was shown that the apparent pKa values
determined from TNS method are generally in good agreement
with the values determined from the micelle titration method,
while both values are significantly lower than those estimated
from modeling. This shows again that the determination of pKa of
amino lipids in a relevant hydrophobic environment is critical in
understanding the ionization behavior of amino lipids.
It is noted that the TNS fluorescence assay for pKa determination relies on the binding of TNS to the positive charges of the
lipid headgroups, which have a relatively smaller size compared
with TNS molecule. As mentioned above, binding of TNS to
lipids is limited by the accessibility of lipids to TNS. Therefore, if
amino lipids bearing multiple amines are used, it might be
challenging for multiple TNS molecules to bind around one lipid
headgroup due to even greater steric hindrance, and therefore, no
increases in TNS fluorescence will be observed even if more than
one amine on a single lipid headgroup are ionized. In fact,
evaluation of the TNS fluorescence of lipid 14 (dibasic amine
with measured pKa around 2.8 and 7.9 (based on the micelle
approach)) at pH 2 showed the same fluorescence value as pH 5,
while the cationic lipid liposome showed much greater surface
charge at pH 2 compared with pH 5. A further evaluation of the
lipid 14 concentration-dependent fluorescence profiles at pH 1
and 5 showed overlapping fluorescence values at all concentration
1912 DOI: 10.1021/la104590k
Zhang et al.
ranges (data not shown). This suggests that TNS does not respond
to two charges on a single lipid molecule, and it is unlikely that the
TNS fluorescence approach will be able to differentiate among the
individual pKa values of the multiple amines on the same lipid
headgroup.
Impact of Lipid pKa on the Interaction between Cationic
Lipids and Model Cell Membranes. The charge state of the
amine headgroups on cationic lipids directly determines surface
charge properties of lipid nanoparticles, which are mostly composed of cationic lipids and neutral lipids and can have a dramatic
impact on the efficacy and toxicity of these lipid nanoparticles as
siRNA delivery vehicles. For example, the delivery of siRNA
using lipid nanoparticles generally needs to overcome several
critical extracellular and intracellular barriers such as blood protein adsorption, biodistribution, cell uptake, endosomal escape,
dissociation of siRNA from delivery vehicles, and binding of
siRNA with RNA interference silencing complex (RISC).36 A
common feature in many of these steps is the involvement of
negatively charged biological components including peptides,
proteins, and most importantly the external and internal cell
membranes. It was hypothesized that the charge state of cationic
lipids mostly affects its biological performance by influencing the
charge-charge interaction between cationic lipids and negatively
charged cell membranes and blood proteins.21-23,37-39 In addition to affecting the interaction with external cell membranes
which happens at physiological pH (7), the charge state of
amino lipids at acidic pH significantly affects the ability of
cationic lipids to interact with internal cell membranes in an
acidified environment such as those in the endosomes (pH 5-6)
and therefore plays an important role in determining the efficiency of endosomal escape of lipid nanoparticles, a key ratelimiting step in siRNA delivery.24,25
(36) Juliano, R.; Bauman, J.; Kang, H.; Ming, X. Mol. Pharmaceutics 2009, 6,
686695.
(37) Xu, Y.; Szoka, F. C., Jr. Biochemistry 1996, 35, 561623.
(38) Zelphati, O.; Szoka, F. C., Jr. Proc. Natl. Acad. Sci. U.S.A. 1996, 93,
114938.
(39) Caracciolo, G.; Pozzi, D.; Amenitsch, H.; Caminiti, R. Langmuir 2007, 23,
87138717.
Zhang et al.
Article
Figure 4. Lysis of membrane-mimicking liposomes by ionizable amino lipids with diverse amine headgroups. Amino lipids tested here all
have the same tail structure of one oleyl and one hexyl cholesteryl ether tail. The pKa values of amino lipids are determined using the micelle
method (see Table 1 for detail). Liposome lysis is conducted in buffer solutions at pH 5.4, 6.0, and 7.5 using carboxyfluorescein as a reporter
for lysis. Extent of liposome lysis is reported as an average of triplicate measurements of lysis activities at 50 M cationic lipids concentration.
DOI: 10.1021/la104590k
1913
Article
Zhang et al.
charge of the headgroup need to be masked during systemic circulation (pH 7.4). It will be interesting to evaluate this hypothesis in
vitro or in vivo and identify the optimal lipid pKa value for siRNA
delivery. However, it is noted that the optimal pKa value could
depend heavily on the extent of acidification in endosomes and
thus could be different when delivering to different cell types or
going through different intracellular pathways. It is further noted
that successful intracellular siRNA delivery depends on not only
the endosomal escape of delivery vehicle, but also the final release
of siRNA from the delivery vehicle, a step which could also be
affected by the pKa of amino lipids and the interaction strength
between amino lipid and siRNA.19,20,39,42 Therefore, it might be
difficult to find a universal optimal lipid pKa value for siRNA
delivery. Finally, it is expected that coupling of the lipid pKa
determination methods described here with methods that can
permit quantitative understanding of endosomal escape efficiency
or membrane interaction mechanism of amino lipids could greatly
help to advance the rational design and use of amino lipid for
siRNA delivery.